New Dawn in Indian Pharma: Why Revised Schedule M Norms Must Be Enforced From January 1
In a decisive move that reverberates across the Indian pharmaceutical
When Indian Pharma Made History: How Wockhardt’s Zaynich Sparked a 27% Share Surge
The stock market waited — and then it roared. In
